Alternatives to umeclidinium/vilanterol
2 same-class SPL records vs umeclidinium/vilanterol - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Anoro Ellipta
About umeclidinium/vilanterol
Anoro Ellipta is a combination medicine used long-term to help people with COPD breathe better. It contains two medicines that open airways.
Used for: Anoro Ellipta is used to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open the airways in your lungs so you can breathe easier. It is not for sudden breathing problems.
2 LAMA / LABA Combination peers (wide set)
glycopyrrolate/formoterol
RxBevespi Aerosphere
Bevespi Aerosphere is used to help manage chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open your airways so you can breathe easier. It is not for sudden breathing problems.
tiotropium/olodaterol
RxStiolto Respimat
Stiolto Respimat is used to treat chronic obstructive pulmonary disease (COPD). This includes chronic bronchitis and emphysema. This medicine helps you breathe better over a long period. Stiolto Respimat is not for sudden COPD symptoms or asthma.
Compare umeclidinium/vilanterol vs glycopyrrolate/formoterol side-by-side →
umeclidinium/vilanterol vs glycopyrrolate/formoterol & tiotropium/olodaterol · FAERS reaction fields
FAERS top-reaction field "Shortness of breath" shows the widest count spread between umeclidinium/vilanterol and glycopyrrolate/formoterol, tiotropium/olodaterol in this extract (1,352-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | umeclidinium/vilanterol | glycopyrrolate/formoterol | tiotropium/olodaterol |
|---|---|---|---|
| Shortness of breath | 1,352 | - | - |
| Cough | 701 | 626 | - |
| Asthma | 604 | 793 | - |
| Using the inhaler incorrectly | 520 | - | - |
| Pneumonia | 509 | 538 | - |
| Chronic obstructive pulmonary disease | 403 | 326 | - |
| Tiredness | 364 | 352 | - |
| Wheezing | 325 | 674 | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
umeclidinium/vilanterol peer mix vs class inventory
Peer mix
0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for LAMA / LABA Combination: 3 drugs.
Frequently Asked Questions
What same-class SPL records sit beside umeclidinium/vilanterol? ▼
Reading a wide LAMA / LABA Combination peer set (2 records)
umeclidinium/vilanterol (Anoro Ellipta) sits in a wide LAMA / LABA Combination peer set (2 of 2 class peers shown). Labeled indication field for umeclidinium/vilanterol: Anoro Ellipta is used to treat chronic obstructive pulmonary disease (COPD).
Top FAERS reaction fields for umeclidinium/vilanterol total 5,414 reports across 10 reactions, set beside glycopyrrolate/formoterol, tiotropium/olodaterol. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for umeclidinium/vilanterol: see also the generic vs brand label guide when reading Anoro Ellipta SPL strings.
Read our methodology - how this data is sourced, computed, and verified.